“Tangeretin Suppresses HER2-Driven Breast Cancer via PI3K AKT MTOR Inhibition and Caspase-Dependent Apoptosis”. Bangladesh Journal of Pharmacology, vol. 21, no. 1, Mar. 2026, pp. 1-10, https://doi.org/10.3329/bjp.v21i1.85717.